Conduit Pharmaceuticals announces 1-for-100 reverse stock split to meet Nasdaq bid price requirement

CDT Equity Inc.

Effective Jan 24, 2025 at 5pm ET; shares begin trading on split-adjusted basis Jan 27 under ticker CDT.
Every 100 shares combined into 1; no fractional shares; cash in lieu for fractional interests.
Post-split outstanding shares reduced to approximately 1.5 million.
Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CDT Equity Inc.: Amendment to Second Amended and Restated Certificate of Incorporation to effectuate a 1-for-100 reverse stock split (effective 2025-01-24).

Change: charter amendment
Effective: 2025-01-24

Exact text from the filing

On January 22, 2025, Conduit Pharmaceuticals Inc. (the “Company”) filed a certificate of amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effectuate a 1-for-100 reverse stock split

View on SEC.gov

Browse all governance changes →

CDT Equity Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-003316

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.